Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Access and Reimbursement for Artificial Intelligence in Radiology: A Japanese Perspective
0
Zitationen
3
Autoren
2026
Jahr
Abstract
Artificial intelligence (AI) is reshaping radiology by improving image reconstruction, workflow efficiency, and decision support.Yet, technological excellence alone does not guarantee clinical adoption.The equation often cited by healthcare economists-value = outcome/cost-captures the essence of why reimbursement matters: innovations must demonstrate measurable improvements in safety, quality, or timeliness of care while remaining economically feasible [1].In Japan, the relationship between regulatory approval and reimbursement is distinctive.Both processes fall under the Ministry of Health, Labor and Welfare (MHLW), with technical evaluation by the Pharmaceuticals and Medical Devices Agency (PMDA).This unified system allows rapid alignment between approval and reimbursement but limits flexibility for post-market evidence evaluation or price revision.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.214 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.071 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.429 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.418 Zit.